🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,88 USD

Máx. histórico

61,25

1785 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-51,22%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-2,96%

Cierre anterior

30,79

Rango de hoy

29,85 – 31,44

Volumen hoy

52.805.827

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
42,69 (puede no estar actualizado)
Dividend yield
5,59% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 23 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,76%
Fecha de pago Importe por participación
31/01/2019 0,3416 USD
08/11/2018 0,3226 USD
02/08/2018 0,3226 USD
10/05/2018 0,3226 USD
01/02/2018 0,3226 USD
09/11/2017 0,3036 USD
02/08/2017 0,3036 USD
10/05/2017 0,3036 USD
01/02/2017 0,3036 USD
08/11/2016 0,2846 USD
03/08/2016 0,2846 USD
11/05/2016 0,2846 USD
03/02/2016 0,2846 USD
04/11/2015 0,2657 USD
05/08/2015 0,2657 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/08/1999 38,07 38,60 37,42 37,54 -2,01% 3,12% 10.945.579
25/08/1999 37,12 38,37 37,12 38,31 +3,36% 3,35% 14.216.774
24/08/1999 36,53 37,30 36,29 37,06 +1,13% 2,76% 12.386.503
23/08/1999 35,52 37,12 35,46 36,65 +4,57% 4,67% 15.827.180
20/08/1999 33,92 35,34 33,62 35,05 +4,79% 5,07% 10.847.768
19/08/1999 32,85 33,56 32,73 33,44 +1,44% 2,53% 5.064.259
18/08/1999 33,68 33,86 32,91 32,97 -2,28% 2,82% 5.891.544
17/08/1999 33,50 33,80 32,73 33,74 +1,97% 3,19% 7.238.029
16/08/1999 32,44 33,44 32,38 33,09 +1,09% 3,29% 6.186.242
13/08/1999 32,26 33,27 31,67 32,73 +1,47% 4,96% 10.798.652
12/08/1999 31,72 33,15 31,61 32,26 +3,03% 4,86% 9.727.261
11/08/1999 31,67 31,72 30,89 31,31 +0,57% 2,62% 7.210.836
10/08/1999 31,72 31,78 30,66 31,13 -2,23% 3,55% 7.964.024
09/08/1999 31,13 31,84 31,13 31,84 +2,48% 2,29% 6.064.084
06/08/1999 31,90 31,90 30,83 31,07 -2,42% 3,35% 7.677.968
05/08/1999 31,72 32,14 30,83 31,84 +0,75% 4,11% 8.467.309
04/08/1999 32,20 32,32 31,43 31,61 -2,38% 2,76% 8.839.371
03/08/1999 32,97 33,09 32,08 32,38 -1,27% 3,06% 7.626.112
02/08/1999 31,90 33,09 31,90 32,79 +2,03% 3,72% 7.921.126
30/07/1999 32,50 32,61 32,08 32,14 -0,37% 1,64% 9.926.888
29/07/1999 32,73 33,15 32,08 32,26 -3,55% 3,26% 10.985.526
28/07/1999 33,21 33,68 32,85 33,44 +0,36% 2,50% 6.134.280
27/07/1999 33,80 33,92 33,15 33,33 -0,53% 2,28% 8.409.655
26/07/1999 33,03 33,68 33,03 33,50 +1,62% 1,97% 7.211.890
23/07/1999 33,27 33,50 32,85 32,97 -1,24% 1,96% 7.475.284
22/07/1999 33,86 34,21 33,21 33,38 -1,57% 2,98% 9.376.279
21/07/1999 34,10 34,69 33,74 33,92 +0,00% 2,78% 9.076.626
20/07/1999 35,10 35,46 33,62 33,92 -3,70% 5,24% 13.073.078
19/07/1999 36,76 36,76 35,10 35,22 -1,82% 4,52% 10.655.518
16/07/1999 35,76 36,29 35,52 35,88 +0,33% 2,16% 8.347.680